EUVIMEDEUVIMED entdecken
Crossref

Letter to the Editor: Natural product intervention in metabolic dysfunction-associated steatotic liver disease: From allyl isothiocyanate to signaling networks

Rui Tian, Yi-Xin Wu, Jie-Yu Guo, Xing-Zhen Chen, Jing-Feng Tang, Ce-Fan Zhou

World Journal of Hepatology · 27.08.2026 · 18 (8)

DOI: 10.4254/wjh.117382 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Hepatology, online erschienen am 27.08.2026. Verfasst von Rui Tian und 5 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pursuit of effective therapeutic agents against metabolic dysfunction-associated steatotic liver disease continues, with natural products offering promise due to their multi-targeting capabilities. A study published in the World Journal of Hepatology by Gao et al demonstrates that allyl isothiocyanate (AITC) alleviates hepatic steatosis and insulin resistance by upregulating the hepatic vitamin D receptor (VDR), which activates the hepatocyte nuclear factor 4 alpha/microsomal triglyceride transfer protein/apolipoprotein B axis to promote lipid export and β-oxidation while suppressing lipogenesis. While compelling, this VDR-centric model exists in isolation, lacking integration with other known AITC targets like the sirtuin 1/AMP-activated protein kinase axis. Furthermore, although the experimental model provides insightful data, it relies exclusively on in vitro studies, awaiting validation in vivo and direct genetic evidence from VDR knockout models to solidify the causal relationship. This commentary aims to elucidate the multifaceted mechanisms of AITC against metabolic dysfunction-associated steatotic liver disease, underscoring its systemic effects on lipid metabolism, insulin sensitivity, and hepatocyte transcriptional reprogramming, which collectively provide a foundation for developing precise, safe, and sustainable therapeutic strategies.

Zitieren

APA

Tian, R., Wu, Y., Guo, J., Chen, X., Tang, J., & Zhou, C. (2026). Letter to the Editor: Natural product intervention in metabolic dysfunction-associated steatotic liver disease: From allyl isothiocyanate to signaling networks. World Journal of Hepatology, 18(8). https://doi.org/10.4254/wjh.117382

Vancouver

Tian R, Wu Y, Guo J, Chen X, Tang J, Zhou C. Letter to the Editor: Natural product intervention in metabolic dysfunction-associated steatotic liver disease: From allyl isothiocyanate to signaling networks. World Journal of Hepatology. 2026;18(8). doi:10.4254/wjh.117382

BibTeX
@article{Tian2026,
  author = {Tian, Rui and Wu, Yi-Xin and Guo, Jie-Yu and Chen, Xing-Zhen and Tang, Jing-Feng and Zhou, Ce-Fan},
  title = {Letter to the Editor: Natural product intervention in metabolic dysfunction-associated steatotic liver disease: From allyl isothiocyanate to signaling networks},
  journal = {World Journal of Hepatology},
  year = {2026},
  volume = {18},
  number = {8},
  doi = {10.4254/wjh.117382}
}
Kostenlos starten →